209 related articles for article (PubMed ID: 17622626)
1. Yellow fever virus NS3 protease: peptide-inhibition studies.
Löhr K; Knox JE; Phong WY; Ma NL; Yin Z; Sampath A; Patel SJ; Wang WL; Chan WL; Rao KRR; Wang G; Vasudevan SG; Keller TH; Lim SP
J Gen Virol; 2007 Aug; 88(Pt 8):2223-2227. PubMed ID: 17622626
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization and polymorphism analysis of the NS2B-NS3 protease from the 2017 Brazilian circulating strain of Yellow Fever virus.
Noske GD; Gawriljuk VO; Fernandes RS; Furtado ND; Bonaldo MC; Oliva G; Godoy AS
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129521. PubMed ID: 31931019
[TBL] [Abstract][Full Text] [Related]
3. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
[TBL] [Abstract][Full Text] [Related]
4. Yellow fever virus NS2B/NS3 protease: hydrolytic properties and substrate specificity.
Kondo MY; Oliveira LC; Okamoto DN; de Araujo MR; Duarte dos Santos CN; Juliano MA; Juliano L; Gouvea IE
Biochem Biophys Res Commun; 2011 Apr; 407(4):640-4. PubMed ID: 21419753
[TBL] [Abstract][Full Text] [Related]
5. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.
Shiryaev SA; Kozlov IA; Ratnikov BI; Smith JW; Lebl M; Strongin AY
Biochem J; 2007 Feb; 401(3):743-52. PubMed ID: 17067286
[TBL] [Abstract][Full Text] [Related]
6. Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
J Biol Chem; 2006 Dec; 281(50):38448-58. PubMed ID: 17052977
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
8. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides.
Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822
[TBL] [Abstract][Full Text] [Related]
9. Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities.
Chambers TJ; Droll DA; Tang Y; Liang Y; Ganesh VK; Murthy KHM; Nickells M
J Gen Virol; 2005 May; 86(Pt 5):1403-1413. PubMed ID: 15831952
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
11. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.
Nall TA; Chappell KJ; Stoermer MJ; Fang NX; Tyndall JD; Young PR; Fairlie DP
J Biol Chem; 2004 Nov; 279(47):48535-42. PubMed ID: 15322074
[TBL] [Abstract][Full Text] [Related]
13. Lyso-myristoyl phosphatidylcholine micelles sustain the activity of Dengue non-structural (NS) protein 3 protease domain fused with the full-length NS2B.
Huang Q; Li Q; Joy J; Chen AS; Ruiz-Carrillo D; Hill J; Lescar J; Kang C
Protein Expr Purif; 2013 Dec; 92(2):156-62. PubMed ID: 24084007
[TBL] [Abstract][Full Text] [Related]
14. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
[TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions.
Chappell KJ; Nall TA; Stoermer MJ; Fang NX; Tyndall JD; Fairlie DP; Young PR
J Biol Chem; 2005 Jan; 280(4):2896-903. PubMed ID: 15494419
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease.
Bera AK; Kuhn RJ; Smith JL
J Biol Chem; 2007 Apr; 282(17):12883-92. PubMed ID: 17337448
[TBL] [Abstract][Full Text] [Related]
18. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the NS2B/NS3 protease complex from seven viruses belonging to different groups inside the genus Flavivirus.
Bessaud M; Pastorino BA; Peyrefitte CN; Rolland D; Grandadam M; Tolou HJ
Virus Res; 2006 Sep; 120(1-2):79-90. PubMed ID: 16504332
[TBL] [Abstract][Full Text] [Related]
20. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
